FFT Wealth Management LLC held its stake in Grifols, S.A. (NASDAQ:GRFS) during the second quarter, according to its most recent disclosure with the SEC. The firm owned 39,458 shares of the biotechnology company’s stock at the end of the second quarter. FFT Wealth Management LLC’s holdings in Grifols, were worth $834,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in GRFS. AKO Capital LLP raised its stake in Grifols, by 5.7% in the second quarter. AKO Capital LLP now owns 12,341,363 shares of the biotechnology company’s stock worth $9,335,000 after buying an additional 667,174 shares during the last quarter. FMR LLC raised its stake in Grifols, by 52.6% in the first quarter. FMR LLC now owns 6,352,581 shares of the biotechnology company’s stock valued at $119,905,000 after buying an additional 2,189,431 shares in the last quarter. Pictet Asset Management Ltd. raised its stake in Grifols, by 7.8% in the second quarter. Pictet Asset Management Ltd. now owns 5,409,186 shares of the biotechnology company’s stock valued at $116,081,000 after buying an additional 390,486 shares in the last quarter. FIL Ltd raised its stake in Grifols, by 0.4% in the first quarter. FIL Ltd now owns 3,689,737 shares of the biotechnology company’s stock valued at $69,644,000 after buying an additional 15,142 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. purchased a new stake in Grifols, during the second quarter valued at approximately $57,845,000. Hedge funds and other institutional investors own 21.93% of the company’s stock.

Shares of Grifols, S.A. (NASDAQ GRFS) traded up 0.50% during mid-day trading on Wednesday, hitting $20.17. 115,733 shares of the stock traded hands. The firm’s 50 day moving average price is $20.58 and its 200 day moving average price is $19.95. Grifols, S.A. has a 12-month low of $14.27 and a 12-month high of $22.83. The firm has a market cap of $27.56 billion, a price-to-earnings ratio of 42.11 and a beta of 0.97.

TRADEMARK VIOLATION NOTICE: “FFT Wealth Management LLC Has $834,000 Position in Grifols, S.A. (GRFS)” was reported by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/fft-wealth-management-llc-has-834000-position-in-grifols-s-a-grfs/1531653.html.

Several analysts have recently issued reports on the stock. Goldman Sachs Group, Inc. (The) lowered shares of Grifols, from a “buy” rating to a “neutral” rating in a research report on Friday, June 30th. BidaskClub lowered shares of Grifols, from a “buy” rating to a “hold” rating in a research report on Friday, June 9th. Bank of America Corporation reiterated a “buy” rating on shares of Grifols, in a research report on Tuesday, July 4th. Finally, Zacks Investment Research lowered shares of Grifols, from a “buy” rating to a “hold” rating in a research report on Friday, May 5th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. Grifols, currently has an average rating of “Hold” and an average price target of $24.00.

About Grifols,

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company specializes in providing infusion solutions, nutrition products, and medical devices for use in hospitals and clinics.

Institutional Ownership by Quarter for Grifols, (NASDAQ:GRFS)

Receive News & Ratings for Grifols S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grifols S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.